PR Archives:  LatestBy Company By Date

Press Release -- December 23rd, 2014
Source: Colt Group

Colt Group S.A. (Colt) Board Changes

Bookmark and Share
Colt, a leading provider of business communications, today announced changes to the composition of its Board.

Tim Hilton will step down as non-executive Director with effect from 31 December 2014. He was appointed to the Board in 1999 and served as Chairman from 2007 to 2013. Mr Hilton is Chairman of DI International, a private equity affiliate of Fidelity Investments, a major shareholder of Colt.

Simon Haslam, Colt’s Chairman, said “On behalf of the Board I would like to thank Tim for his leadership, support and hard work over the last fifteen years. We are grateful to Tim for his valuable contribution to Colt.  Colt has benefitted greatly from his wisdom and guidance.

Colt also announced today that Jennifer Uhrig will join the Board, with the appointment intended to take effect from 1 January 2015.  Jennifer will be a non-executive Director.  Like Tim, she is affiliated to one of Colt’s major shareholders.

Jennifer spent 22 years at Fidelity Investments, initially as the Telecommunications analyst in the Equity Group and from 1993 as a portfolio manager. Since retiring from money management in 2009, she has served in an advisory role at Fidelity and now sits on the boards of Forum Pharmaceuticals, a Fidelity affiliate and Geode Capital Management. Prior to joining Fidelity, Jennifer was a research associate for Fred Alger Management, in New York. Jennifer is also a member of the Board of Overseers of the Tuck School of Business at Dartmouth College, the Board of Trustees of the New England Conservatory, and the Board of Trustees of the Massachusetts Eye and Ear Infirmary.

Simon Haslam, Colt’s Chairman, said “I am delighted that Jennifer is joining us. Her considerable depth of knowledge and experience in finance, global communication services and technology makes her a welcome addition to the Colt Board.”
There are no other matters requiring disclosure in accordance with Listing Rule 9.6.13 in respect of Ms Uhrig’s appointment as a Director of the Company.

Enquiries: Caroline Griffin Pain
Company Secretary

Morten Singleton
VP Investor Relations
Tel: +44 (0) 20 7863 5314
Mobile: +44 (0) 7535 445159

PR Archives: Latest, By Company, By Date